跳至主要内容
临床试验/NL-OMON40068
NL-OMON40068已完成4 期

Immune response after Human Papillomavirus vaccination in patients with automimmune disease - HPV study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12 至 17(—)

入选标准

  • Females Who have one of the following immunsystem disorder:
  • a. Juvenile Idiopathic Arthritis
  • b. Systemic Lupus Erythematosus
  • c. Juvenile Dermatomyositis
  • Current co-medication: all co-medication such as Methotrexate, etanercept, anakinra or infliximab may be continued.
  • And who are in the following age groups:
  • a. 12 years (these girls are vaccinated via the National Vaccination Program from September 2009)
  • b. 13-17 years (these girls are vaccinated during a national vaccination campaign from March-May 2009)

排除标准

  • - Refusal to be vaccinated with the HPV vaccine
  • - Allergic reactions to one of the components of the vaccine.
  • - Acute, severe disease accompanied with fever. In this case, the moment of vaccination will be postponed for 1 month. A light infection, such as an upper airway infection, is not a reason to postpone the vaccination.
  • -Proven or suspected cervix carcinoma
  • -failure to comply

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验